EMEA-000176-PIP01-07-M05

Key facts

Invented name
Colobreathe
Active substance
Colistimethate sodium
Therapeutic area
Infectious diseases
Decision number
P/0173/2017
PIP number
EMEA-000176-PIP01-07-M05
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of Pseudomonas aeruginosa pulmonary infection / colonisation in patients with cystic fibrosis
Route(s) of administration
Inhalation use
Contact for public enquiries
TEVA B.V.
United Kingdom
Tel. +44 2075407058
E-mail: rina.joshi@tevaeu.com
 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating